Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc.SNOA · Entity 8177 | Controller | July 09, 2026 | July 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sonoma Pharmaceuticals, Inc.
Report date July 09, 2026 · Filed July 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 32,750 |
Reported balance
After 2026-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-09 · Grant · Acquired 7,500 · Balance 32,750 F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F3: The RSUs were awarded and granted to Mr. Dal Poggetto for services performed. F2: The RSUs vest on the third anniversary of the grant date, or upon change of control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
F2: The RSUs vest on the third anniversary of the grant date, or upon change of control.
F3: The RSUs were awarded and granted to Mr. Dal Poggetto for services performed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2026 Filed Jul 10, 2026 00:46 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantRestricted Stock Units · Derivative | 7,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-005418 · ownership.xml · derivative · entry 1 Dal Poggetto John · CIK 0001791040 · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,750 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F3 · price: The RSUs were awarded and granted to Mr. Dal Poggetto for services performed. F2 · derivative.exercise_date: The RSUs vest on the third anniversary of the grant date, or upon change of control. F2 · derivative.expiration_date: The RSUs vest on the third anniversary of the grant date, or upon change of control. Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 22:21 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-000031 · ownership.xml · derivative · entry 1 Dal Poggetto John · CIK 0001791040 · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,250 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F3 · price: The RSUs were awarded and granted to Mr. Dal Poggetto for services performed. F2 · derivative.exercise_date: The RSUs vest on the third anniversary of the grant date, or upon change of control. F2 · derivative.expiration_date: The RSUs vest on the third anniversary of the grant date, or upon change of control. Read SEC document |
| June 19, 2025 Filed Jun 20, 2025 21:00 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-25-004663 · ownership.xml · derivative · entry 1 Dal Poggetto John · CIK 0001791040 · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,250 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F3 · price: The RSUs were awarded and granted to Mr. Dal Poggetto for services performed. F2 · derivative.exercise_date: The RSUs vest on the third anniversary of the grant date, or upon change of control. F2 · derivative.expiration_date: The RSUs vest on the third anniversary of the grant date, or upon change of control. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 22:02 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantRestricted Stock Units · Derivative | 7,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001683168-25-000078 · ownership.xml · derivative · entry 1 Dal Poggetto John · CIK 0001791040 · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,250 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock. F3 · price: The RSUs were awarded and granted to Mr. Dal Poggetto for services performed as part of the Company's annual equity grant. F2 · derivative.exercise_date: The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control. F2 · derivative.expiration_date: The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:05 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-24-004423 · ownership.xml · nonDerivative · entry 1 Dal Poggetto John · CIK 0001791040 · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · price: The shares of common stock were awarded and granted as Restricted Stock Units to Mr. Dal Poggetto for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date. Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 22:25 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantStock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $0.18 | Not disclosed |
DisclosureSEC source: 0001683168-23-009154 · ownership.xml · derivative · entry 1 Dal Poggetto John · CIK 0001791040 · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 50,000 shares Expires 2033-12-29 F1 · price: The options were awarded and granted to Mr. Dal Poggetto for services performed as part of the Company's annual grant of stock options. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 20:15 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantCommon Stock, $0.0001 par value | 3,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-20-001272 · ownership.xml · nonDerivative · entry 1 Dal Poggetto John · CIK 0001791040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,201 F1 · price: The shares were granted pursuant to the mutual separation and release agreement dated April 14, 2020. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:02 UTC | Sonoma Pharmaceuticals, Inc. SNOA · Entity 8177 | GrantStock option (right to buy) · Derivative | 13,000 | Not disclosed Strike: $4.36 | Not disclosed |
DisclosureSEC source: 0001683168-20-000019 · ownership.xml · derivative · entry 1 Dal Poggetto John · CIK 0001791040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,496 Underlying: Common stock · 13,000 shares Expires 2029-12-31 F2 · price: The options were awarded and granted to Mr. Dal Poggetto for services performed. F1 · derivative.exercise_date: The options vest in two equal tranches: the first half vest on 7/1/2020 and the remaining half vest on 12/31/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.